-
1
-
-
0013163515
-
-
Woodcliff Lake, NJ. Eisai Co., Ltd
-
ARICEPT. [package insert]. Woodcliff Lake, NJ. Eisai Co., Ltd; 2006.
-
(2006)
ARICEPT. [Package Insert]
-
-
-
2
-
-
40549106116
-
Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study (Journal of Alzheimer's Disease)
-
Bakchine S, Loft H. 2008. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study. Alzheimers Dis 13(1): 97-107. (Pubitemid 351365621)
-
(2008)
Journal of Alzheimer's Disease
, vol.13
, Issue.1
, pp. 97-107
-
-
Bakchine, S.1
Loft, H.2
-
3
-
-
42749100518
-
Cholinesterase inhibitors for Alzheimer's disease
-
Birks J. 2006. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1: CD005593.
-
(2006)
Cochrane Database Syst Rev
, vol.1
-
-
Birks, J.1
-
4
-
-
0032926540
-
The effects of donepezil in Alzheimer's disease - Results from a multinational trial
-
DOI 10.1159/000017126
-
Burns A, Rossor M, Hecker J, et al. 1999. The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord 10(3): 237-244. (Pubitemid 29224502)
-
(1999)
Dementia and Geriatric Cognitive Disorders
, vol.10
, Issue.3
, pp. 237-244
-
-
Burns, A.1
Rossor, M.2
Hecker, J.3
Gauthier, S.4
Petit, H.5
Moller, H.-J.6
Rogers, S.L.7
Friedhoff, L.T.8
-
5
-
-
46749120366
-
5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease
-
Chuang ATT, Foley A, Pugh PL. 2006. 5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease. Alzheimer & Dementia 2: S631-S632.
-
(2006)
Alzheimer & Dementia
, vol.2
-
-
Chuang, A.T.T.1
Foley, A.2
Pugh, P.L.3
-
6
-
-
0027985334
-
The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia
-
Cummings JL, Mega M, Gray K, et al. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314. (Pubitemid 24382728)
-
(1994)
Neurology
, vol.44
, Issue.12
, pp. 2308-2314
-
-
Cummings, J.L.1
Mega, M.2
Gray, K.3
Rosenberg-Thompson, S.4
Carusi, D.A.5
Gornbein, J.6
-
7
-
-
39749121622
-
The development of the Alzheimer's Carers' Quality of Life Instrument (ACQLI)
-
[Abstr 88]
-
Doward LC. 1997. The development of the Alzheimer's Carers' Quality of Life Instrument (ACQLI) [Abstr 88]. Qual of Life Res 6(suppl 7-8): 639.
-
(1997)
Qual of Life Res
, vol.6
, Issue.SUPPL. 7-8
, pp. 639
-
-
Doward, L.C.1
-
8
-
-
44149105604
-
The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats
-
Foley AG, Hirst WD, Gallagher HC, et al. 2008. The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacology 54(8): 1166-1174.
-
(2008)
Neuropharmacology
, vol.54
, Issue.8
, pp. 1166-1174
-
-
Foley, A.G.1
Hirst, W.D.2
Gallagher, H.C.3
-
9
-
-
0016823810
-
Mini-mental state. A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR. 1975. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198.
-
(1975)
J Psychiatr Res
, vol.12
, Issue.3
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
10
-
-
36049013008
-
Polysialic acid-neural cell adhesion molecule in brain plasticity: From synapses to integration of new neurons
-
DOI 10.1016/j.brainresrev.2007.05.014, PII S0165017307000999
-
Gascon E, Vutskits L, Kiss JZ. 2007. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 56(1): 101-118. (Pubitemid 350100865)
-
(2007)
Brain Research Reviews
, vol.56
, Issue.1
, pp. 101-118
-
-
Gascon, E.1
Vutskits, L.2
Kiss, J.Z.3
-
11
-
-
0033193134
-
Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia
-
Gélinas I, Gauthier L, McIntyre M, et al. 1999. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 53: 471-481.
-
(1999)
Am J Occup Ther
, vol.53
, pp. 471-481
-
-
Gélinas, I.1
Gauthier, L.2
McIntyre, M.3
-
12
-
-
34548639338
-
A neuropsychological test battery for use in alzheimer disease clinical trials
-
DOI 10.1001/archneur.64.9.1323
-
Harrison J, Minassian SL, Jenkins L, et al. 2007. A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol 64(9): 1323-1329. (Pubitemid 47403089)
-
(2007)
Archives of Neurology
, vol.64
, Issue.9
, pp. 1323-1329
-
-
Harrison, J.1
Minassian, S.L.2
Jenkins, L.3
Black, R.S.4
Koller, M.5
Grundman, M.6
-
13
-
-
33751162382
-
6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
-
DOI 10.1016/j.ejphar.2006.09.049, PII S0014299906010454
-
Hirst WD, Stean TO, Rogers DC, et al. 2006. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553(1-3): 109-119. (Pubitemid 44779592)
-
(2006)
European Journal of Pharmacology
, vol.553
, Issue.1-3
, pp. 109-119
-
-
Hirst, W.D.1
Stean, T.O.2
Rogers, D.C.3
Sunter, D.4
Pugh, P.5
Moss, S.F.6
Bromidge, S.M.7
Riley, G.8
Smith, D.R.9
Bartlett, S.10
Heidbreder, C.A.11
Atkins, A.R.12
Lacroix, L.P.13
Dawson, L.A.14
Foley, A.G.15
Regan, C.M.16
Upton, N.17
-
14
-
-
47849132215
-
Predictors of placebo group decline in the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease
-
Irizarry MC, Webb DJ, Bains C, et al. 2008. Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-cog) in 24 week clinical trials of Alzheimer's disease. J Alzheimers Dis 14(3): 301-311. (Pubitemid 352040044)
-
(2008)
Journal of Alzheimer's Disease
, vol.14
, Issue.3
, pp. 301-311
-
-
Irizarry, M.C.1
Webb, D.J.2
Bains, C.3
Barrett, S.J.4
Lai, R.Y.5
Laroche, J.P.6
Hosford, D.7
Maher-Edwards, G.8
Weil, J.G.9
-
16
-
-
4444229993
-
Disease stage in Alzheimer disease and treatment effects of rivastigmine
-
DOI 10.1097/01.wad.0000127445.00442.a1
-
Kurz A, Farlow M, Quarg P, Spiegel R. 2004. Disease stage in Alzheimer disease and treatment effects of rivastigmine. Alzheimer Dis Assoc Disord 18(3): 123-128. (Pubitemid 39202187)
-
(2004)
Alzheimer Disease and Associated Disorders
, vol.18
, Issue.3
, pp. 123-128
-
-
Kurz, A.1
Farlow, M.2
Quarg, P.3
Spiegel, R.4
-
17
-
-
77957240989
-
Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease
-
Maher-Edwards G, Zvartau-Hind M, Hunter AJ, et al. 2010. Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease. Curr Alzheimer Res 7(5): 374-385.
-
(2010)
Curr Alzheimer Res
, vol.7
, Issue.5
, pp. 374-385
-
-
Maher-Edwards, G.1
Zvartau-Hind, M.2
Hunter, A.J.3
-
18
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-944.
-
(1984)
Neurology
, vol.34
, Issue.7
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
-
19
-
-
0035210592
-
6 receptors in memory formation
-
Meneses A. 2001. Role of 5-HT6 receptors in memory formation. Drug News Perspect 14(7): 396-400. (Pubitemid 33140705)
-
(2001)
Drug News and Perspectives
, vol.14
, Issue.7
, pp. 396-400
-
-
Meneses, A.1
-
20
-
-
28044437798
-
6 receptors: A novel target for cognitive enhancement
-
DOI 10.1016/j.pharmthera.2005.05.001, PII S0163725805000975
-
Mitchell ES, Neumaier JF. 2005. 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108(3): 320-333. (Pubitemid 41691871)
-
(2005)
Pharmacology and Therapeutics
, vol.108
, Issue.3
, pp. 320-333
-
-
Mitchell, E.S.1
Neumaier, J.F.2
-
21
-
-
0037468873
-
6 receptor antagonist
-
DOI 10.1021/jm021085c
-
Riemer C, Borroni E, Levet-Trafit B, et al. 2003. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6- pyrrolidin-1-ylpyridine-4-sulfonyl) phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46(7): 1273-1276. (Pubitemid 36428233)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.7
, pp. 1273-1276
-
-
Riemer, C.1
Borroni, E.2
Levet-Trafit, B.3
Martin, J.R.4
Poli, S.5
Porter, R.H.P.6
Bos, M.7
-
22
-
-
33745266146
-
Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
-
Risner ME, Saunders AM, Altman JF, et al. 2006. Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6(4): 246-254.
-
(2006)
Pharmacogenomics J
, vol.6
, Issue.4
, pp. 246-254
-
-
Risner, M.E.1
Saunders, A.M.2
Altman, J.F.3
-
23
-
-
0032507788
-
Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study
-
DOI 10.1001/archinte.158.9.1021
-
Rogers SL, Doody RS, Mohs RC, Friedhoff LT. 1998. Donepezil improves cognition and global function in Alzheimer's disease: A 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 158(9): 1021-1031. (Pubitemid 28213580)
-
(1998)
Archives of Internal Medicine
, vol.158
, Issue.9
, pp. 1021-1031
-
-
Rogers, S.L.1
Doody, R.S.2
Mohs, R.C.3
Friedhoff, L.T.4
-
24
-
-
0027534657
-
Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
-
Roman GC, Tatemichi TK, Erkinjuntti T, et al. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-260.
-
(1993)
Neurology
, vol.43
, Issue.2
, pp. 250-260
-
-
Roman, G.C.1
Tatemichi, T.K.2
Erkinjuntti, T.3
-
25
-
-
0021520020
-
A new rating scale for Alzheimer's disease
-
Rosen WG, Mohs RC, Davis KL. 1984. A new rating scale for Alzheimer's disease. Am J Psychiatr 141(11): 1356-1364.
-
(1984)
Am J Psychiatr
, vol.141
, Issue.11
, pp. 1356-1364
-
-
Rosen, W.G.1
Mohs, R.C.2
Davis, K.L.3
-
26
-
-
0033528436
-
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
-
Rösler M, Anand R, Cicin-Sain A, et al. 1999. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Br Med J 318(7184): 633-638.
-
(1999)
Br Med J
, vol.318
, Issue.7184
, pp. 633-638
-
-
Rösler, M.1
Anand, R.2
Cicin-Sain, A.3
-
27
-
-
0030862602
-
Validity and reliability of the Alzheimer's Disease cooperative study-clinical global impression of change. The Alzheimer's Disease Cooperative Study
-
Schneider LS, Olin JT, Doody RS, et al. 1997. Validity and reliability of the Alzheimer's Disease cooperative study-clinical global impression of change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 11(Suppl 2): S22-S32.
-
(1997)
Alzheimer Dis Assoc Disord
, vol.11
, Issue.SUPPL. 2
-
-
Schneider, L.S.1
Olin, J.T.2
Doody, R.S.3
-
28
-
-
0034720864
-
A 5-month, randomized, placebo-controlled trial of galantamine in AD
-
Tariot PN, Solomon PR, Morris JC, et al. 2000. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 54(12): 2269-2276. (Pubitemid 30416277)
-
(2000)
Neurology
, vol.54
, Issue.12
, pp. 2269-2276
-
-
Tariot, P.N.1
Solomon, P.R.2
Morris, J.C.3
Kershaw, P.4
Lilienfeld, S.5
Ding, C.6
-
30
-
-
66349111984
-
Donepezil in the treatment of patients with Alzheimer's disease
-
Tsuno N. 2009. Donepezil in the treatment of patients with Alzheimer's disease. Expert Rev Neurother 9(5): 591-598.
-
(2009)
Expert Rev Neurother
, vol.9
, Issue.5
, pp. 591-598
-
-
Tsuno, N.1
-
31
-
-
46749118971
-
6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease
-
DOI 10.1016/j.nurt.2008.05.008, PII S1933721308001001
-
Upton N, Chuang TT, Hunter AJ, Virley DJ. 2008. 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 5(3): 458-469. (Pubitemid 351952494)
-
(2008)
Neurotherapeutics
, vol.5
, Issue.3
, pp. 458-469
-
-
Upton, N.1
Chuang, T.T.2
Hunter, A.J.3
Virley, D.J.4
-
32
-
-
43249122280
-
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: A randomised phase II trial
-
Wilcock GK, Black SE, Hendrix SB, et al. 2008. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol 7(6): 483-493.
-
(2008)
Lancet Neurol
, vol.7
, Issue.6
, pp. 483-493
-
-
Wilcock, G.K.1
Black, S.E.2
Hendrix, S.B.3
-
33
-
-
0034627263
-
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial
-
Galantamine International-1 Study Group
-
Wilcock GK, Lilienfeld S, Gaens E. Galantamine International-1 Study Group. 2000. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Br Med J 321(7274): 1445-1449.
-
(2000)
Br Med J
, vol.321
, Issue.7274
, pp. 1445-1449
-
-
Wilcock, G.K.1
Lilienfeld, S.2
Gaens, E.3
-
34
-
-
0026688466
-
Alzheimer disease assessment scale: Useful for both early detection and staging of dementia of the Alzheimer type
-
Zec RF, Landreth ES, Vicari SK, et al. 1992. Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 6(2): 89-102.
-
(1992)
Alzheimer Dis Assoc Disord
, vol.6
, Issue.2
, pp. 89-102
-
-
Zec, R.F.1
Landreth, E.S.2
Vicari, S.K.3
|